ment (
. Alternative splicing generates were found to be coexpressed in the otic epithelium throughout development (data not shown). Taken totwo Fgfr1 isoforms, the IIIb and IIIc forms (Werner et al., 1992). By using isoform-specific probes, Fgfr1 variants gether, Fgfr1 is expressed at several stages of the devel- Figure 1F ). To verify Fgfr1 inactivation by the Foxg1-Cre allele, we analyzed spatioand three rows of OHCs that extends through the cochlear duct (Figure 2A ) was disrupted in both hypotemporal expression of Fgfr1 in Fgfr1 ⌬flox/flox ;Foxg1-Cre/ϩ embryos using a probe specific for the region deleted morphs. In the milder Fgfr1 n7/n7 mice, the third OHC row was missing throughout the length of the cochlear duct by Cre-mediated recombination. As analyzed at E10.5, E11.5, E13.5, and E16.5, the otocyst, but not the sur-( Figure 2B ). In the stronger Fgfr1 n15YF/n15YF mice, similar perturbations were seen in the lower half of the cochleas. rounding mesenchyme, of the conditionally inactivated embryos was devoid of Fgfr1 expression ( Figure 1G ).
In contrast, the sensory epithelium of the upper half of their cochleas was arranged in patches (open arrows in
These results indicate that Foxg1-Cre-mediated recombination is restricted to the otocyst and that it occurs Figure 2C ) rather than as continuous rows as seen in controls. The gaps (asterisk in Figure 2C ) between the at the initial stages of Fgfr1 expression. We further confirmed tissue specificity of Cre-mediated recombination patches showed no signs of differentiation of HCs or supporting cells. In contrast to these disturbances in by crossing Foxg1-Cre mice with Z/AP reporter mice, which express placental alkaline phosphatase upon recellular development within the OC, cochlear morpho- 
combination (Lobe et al., 1999). Consistent with earlier
phalloidin-stained cochlear surface specimens prepared from these mutants showed a severely disrupted data on E8.5-E11.5 embryos (Hé bert and McConnell, 2000), the E13.5 double transgenic embryos (Foxg1-OC. As compared to Fgfr1 n15YF/n15YF hypomorphs, the sensory patches were reduced in size, and they mainly Cre/ϩ;Z/AP/ϩ) showed alkaline phosphatase staining in distinct, ectoderm-derived head structures, including comprised IHCs and supporting cells ( Figure 2D ). Similar to the hypomorphs, the upper half of cochleas of the otocyst. Cre-mediated recombination was seen throughout the otic epithelium, including the nascent Fgfr1 ⌬flox/flox ;Foxg1-Cre/ϩ mice was more severely perturbed than the lower half. Only very low numbers of cochlear duct, and in the neurons of the cochleovestibular ganglion, which are derived from the otic epithelium OHCs were formed, and these were located in the lower part of the cochleas. At postnatal day 0 (P0), the total ( Figure 1H ). The surrounding mesenchyme was negative. Thus, although Fgfr1 is expressed both in the epinumber of differentiating HCs averaged 2212 Ϯ 150 (n ϭ 6 cochleas) in controls and 302 Ϯ 54 (n ϭ 9 cochleas) thelium and mesenchyme of the developing cochlea, our strategy provided a tool to study the role of Fgfr1 in Fgfr1 ⌬flox/flox ;Foxg1-Cre/ϩ mutants (the apical region of the cochleas comprising immature HCs was not inspecifically in the epithelium, including HCs and supporting cells of the OC as well as their precursors.
cluded in the counts). By counting differentiating OHCs only, these values were 1702 Ϯ 112 (n ϭ 6) and 37 Ϯ Similar to the hypomorphs, Fgfr1 ⌬flox/flox ;Foxg1-Cre/ϩ mutants died within 24 hr after birth. Around birth, 12 (n ϭ 9), respectively. A comparable phenotype was seen in Fgfr1 flox/flox ;Foxg1-Cre/ϩ mice (data not shown). Thus, Fgfr1 regulates the numbers of HCs and supporting cells formed in a dose-dependent fashion, and interestingly, the requirement for Fgfr1 varies along the length of the cochlear duct. In contrast to the OC, the morphology of the vestibular organs of the inner ear appeared normal in Fgfr1 ⌬flox/flox ;Foxg1-Cre/ϩ mice at birth. The presence of a normal complement of vestibular HCs was verified by using calretinin as a marker for these cells (Figures 2H and 2I) .
We examined whether defects in cellular death, differentiation, fate specification, or proliferation account for the altered phenotype. In transverse sections at birth, the global morphology of the cochleas of Fgfr1 ⌬flox/flox ; Foxg1-Cre/ϩ mice was largely normal, except that frequently the cochleas were slightly shorter than in controls (data not shown). Between E13.5 and birth, morphological analysis and TUNEL staining ( Figures 2E-2G , and data not shown) showed no differences in the extent of cell death in the ventral wall of the cochlear duct The possibility still remained that the generation of the (data not shown). In the cochleas of Fgfr1 ⌬flox/flox ;Foxg1-pool of precursor cells giving rise to the OC is affected by Cre/ϩ mice, the specification markers showed a very Fgfr1 mutations. In the mouse, these precursors exit restricted expression (data not shown). These data indithe cell cycle between E12 and E15 (Ruben, 1967). As cate first, that there are no molecular signs of HC specifiassessed by bromodeoxyuridine (BrdU) incorporation, cation or differentiation in the gap regions and second, Fgfr1 ⌬flox/flox ;Foxg1-Cre/ϩ mice showed a reduction in that the remaining HCs in the sensory patches undergo proliferation rate in the ventral wall of the cochlear duct. normal differentiation. Together with the fact that the Attenuation of proliferation was evident already at E12, altered phenotypes were evident already between E15.5 but became very prominent between E13.5 and E15.5 and E16.5 (data not shown), at the onset of cellular ( Figures 4C and 4D) . Quantitative analysis performed differentiation, these data suggest that Fgfr1 mutations between E13.5 and E14.5 revealed highly significant difact on developmental events occurring before specificaferences (p Ͻ 0.005) between mutants (7.7 Ϯ 2.4 BrdUtion and differentiation processes. labeled cells in the GER per section, n ϭ 12 cochleas) To determine whether early patterning defects could and control littermates (57.4 Ϯ 13.5, n ϭ 12). At E14.5 explain the altered cochlear phenotype, we examined and thereafter, impaired proliferation resulted in a thinner GER and a marked reduction in the level of Nt-3, otocysts of Fgfr1 ⌬flox/flox ;Foxg1-Cre/ϩ mutants at E10.5 which marks the presumptive inner ear sensory epithelia found in the neurons of the cochleovestibular ganglion and, similar to Fgfr1, in the GER of the cochlear duct ( Figures 4E and 4F) (Pirvola et al., 1992) . Notably, no differences in proliferation rate between mutants and ( Figure 4H ). Available data on neurogenin1 and neurotrophin knockout mice, in which the cochleovestibular controls were seen in the dorsal, nonsensory wall of the cochlear duct (Figures 4C and 4D) 
